Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Interest & Investment Income (2009 - 2026)

Updated

Vertex Pharmaceuticals' Interest & Investment Income was $120.6 million in Q2 2026, up 1.6% from $118.7 million a year earlier and up 5.1% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vertex Pharmaceuticals' Interest & Investment Income was $483 million through Jun 30, 2026, down 2.8% year-over-year; for FY2025, it was $490.9 million, down 17.9% from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 85.7% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $598.1 million in FY2024 (-2.7%), $614.7 million in FY2023 (+325.1%), $144.6 million in FY2022 and $4.9 million in FY2021 (-77.9%).
  • Quarterly Interest & Investment Income has moved between $1.1 million (Q3 2021) and $181.2 million (Q1 2024) over five years.
  • Compared with a year earlier, Interest & Investment Income was higher in 1 of the last eight quarters, with an average decline of 15.0%.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q2 2022 (growth of 881.8%); the worst was Q3 2021 (a decline of 64.5%).
  • Per Business Quant data, VRTX's Interest & Investment Income in the three quarters before Q2 2026 was $114.8 million (Q1 2026), $121.9 million (Q4 2025) and $125.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 219.00 Mn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 80.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 120.60 Mn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.60 Mn
Mar 31, 2026 114.80 Mn
Dec 31, 2025 121.90 Mn
Sep 30, 2025 125.70 Mn
Jun 30, 2025 118.70 Mn
Mar 31, 2025 117.90 Mn
Dec 31, 2024 128.20 Mn
Sep 30, 2024 132.20 Mn
Jun 30, 2024 156.50 Mn
Mar 31, 2024 181.20 Mn
Dec 31, 2023 179.50 Mn
Sep 30, 2023 167.90 Mn
Jun 30, 2023 144.70 Mn
Mar 31, 2023 122.60 Mn
Dec 31, 2022 86.00 Mn
Sep 30, 2022 46.20 Mn
Jun 30, 2022 10.80 Mn
Mar 31, 2022 1.60 Mn
Dec 31, 2021 1.20 Mn
Sep 30, 2021 1.10 Mn
API Access

Vertex Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=VRTX&period=max&api_key=YOUR_API_KEY